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Abstract
The health care field has integrated advances into digital technology at an accelerating pace to improve health behavior, health
care delivery, and cost-effectiveness of care. The realm of behavioral science has embraced this evolution of digital health,
allowing for an exciting roadmap for advancing care by addressing the many challenges to the field via technological innovations.
Digital therapeutics offer the potential to extend the reach of effective interventions at reduced cost and patient burden and to
increase the potency of existing interventions. Intervention models have included the use of digital tools as supplements to standard
care models, as tools that can replace a portion of treatment as usual, or as stand-alone tools accessed outside of care settings or
direct to the consumer. To advance the potential public health impact of this promising line of research, multiple areas warrant
further development and investigation. The Center for Technology and Behavioral Health (CTBH), a P30 Center of Excellence
supported by the National Institute on Drug Abuse at the National Institutes of Health, is an interdisciplinary research center at
Dartmouth College focused on the goal of harnessing existing and emerging technologies to effectively develop and deliver
evidence-based interventions for substance use and co-occurring disorders. The CTBH launched a series of workshops to encourage
and expand multidisciplinary collaborations among Dartmouth scientists and international CTBH affiliates engaged in research
related to digital technology and behavioral health (eg, addiction science, behavioral health intervention, technology development,
computer science and engineering, digital security, health economics, and implementation science). This paper summarizes a
workshop conducted on the Development and Evaluation of Digital Therapeutics for Behavior Change, which addressed (1)
principles of behavior change, (2) methods of identifying and testing the underlying mechanisms of behavior change, (3) conceptual
frameworks for optimizing applications for mental health and addictive behavior, and (4) the diversity of experimental methods
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and designs that are essential to the successful development and testing of digital therapeutics. Examples were presented of
ongoing CTBH projects focused on identifying and improving the measurement of health behavior change mechanisms and the
development and evaluation of digital therapeutics. In summary, the workshop showcased the myriad research targets that will
be instrumental in promoting and accelerating progress in the field of digital health and health behavior change and illustrated
how the CTBH provides a model of multidisciplinary leadership and collaboration that can facilitate innovative, science-based
efforts to address the health behavior challenges afflicting our communities.
(JMIR Ment Health 2020;7(2):e16751)  doi: 10.2196/16751
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Introduction
Over the last 25 years, scientists in the fields of addiction science
and mental health have studied how to enhance treatment
outcomes, how to improve the dissemination and
implementation of effective treatments, and how to reach a
greater proportion of the population experiencing behavioral
health challenges. Barriers to success have included substandard
screening and identification of cases, limited numbers of trained
personnel, high burden associated with training, poor fidelity
and integrity of treatment delivery, low pay for providers, high
costs for delivering the most effective interventions, stigma and
burden associated with seeking treatment, and limited
individualization and personalization of treatment.
Broadly speaking, the health care field has integrated numerous
advances in digital technology at an accelerating pace to improve
health behavior, health care delivery, and cost-effectiveness of
care. This area of science, often referred to as digital health,
has been embraced within the realm of behavioral science,
allowing for an exciting roadmap for advancing care by
addressing the many challenges to the field via technological
innovations [1-4]. Technology-delivered treatments, commonly
referred to as digital therapeutics, offer the potential to extend
the reach of evidence-based interventions at reduced cost and
patient burden and to increase the potency of existing
interventions. Delivering on these promises has substantial
public health implications, given that the majority of people
with behavioral health needs are not receiving treatment of any
kind, and only the minority of those who do receive treatment
are provided with an evidence-based intervention. Multiple
studies have demonstrated that treatment models assisted by
computer-, Web-, or smartphone-based delivery of
evidence-based interventions improve access to care, reduce
costs, and improve the efficiency of treatment delivery [1-4].
Intervention models have included the use of digital tools as
supplements to standard care models, as tools that can replace
a portion of treatment as usual, or as stand-alone tools accessed
outside of care settings or direct to the consumer. Indeed, digital
therapeutics have progressed to such an extent that the US Food
and Drug Administration (FDA) recently launched an initiative
to incorporate digital health into mainstream medical practice
[5]. This significant step acknowledges the potential of and the
growing evidence for digital therapeutics. The FDA has further
defined a class of digital therapeutics as mobile medical
applications, software apps that meet the definition of a medical
device, that is, performing patient-specific analysis and
providing patient-specific diagnosis or treatment
recommendations, and at least one mobile app has received
FDA permission for marketing [6,7].
However, to further advance the potential public health impact
of this promising line of research, several areas warrant
development and investigation. Although some digital
therapeutics for health behavior problems have been deemed
effective, effect sizes to date have been generally small to
medium, and treatment mechanisms have been understudied.
To address this problem, it is essential to focus more research
on identifying and understanding specific mechanisms relevant
to health behavior change. Importantly, direct comparisons
between digital therapeutics and well-understood traditionally
delivered interventions may provide the clues necessary for
achieving this goal and developing more potent interventions
[8]. Given their on-demand availability and opportunities for
personalization, digital therapeutics may impact the rate and
nature by which health behavior change occurs. An increased
understanding of the active ingredients and mediators of
outcome from such interventions can greatly enhance future
efforts to optimize development efforts. Such progress could
move the digital health field beyond direct adaptations of
existing face-to-face interventions to better harness the dynamic
potential of technology in collecting data about individuals in
unprecedented ways (and in real time) and in intervening at the
exact moments when individuals may be maximally motivated
and receptive [9].
Optimization and acceleration of the development and evaluation
of digital therapeutics also require advances in the measures
and methods used to study treatment processes, mechanisms,
and outcomes. Understanding how an intervention produces
changes in cognitive, behavioral, or environmental factors that
are then, in turn, causally related to health behavior change (eg,
reduction in drug use) allows for the identification of more
specific treatment targets, which, in turn, permit refinement and
optimization of subsequent iterations of an intervention [8].
Continued development of more granular, objective, and valid
measures of important mechanism constructs and processes and
treatment outcome variables is also essential for the
advancement of health behavior change research and
development. Technological and data analytic advances offer
exciting new approaches for obtaining and interpreting more
meaningful and ecologically valid data that can be readily
collected in the natural environment over substantial periods.
Finally, the pace of science in the realm of digital health can
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greatly benefit from explicit methodological frameworks to
guide research efforts and the application of innovative
experimental designs. Several novel and underused
methodological approaches are relevant to developing and
evaluating digital therapeutics that can supplement the findings
from traditional randomized controlled trials (RCTs) [10-13].
Such approaches include flexible, rigorous, and efficient
methods, which can help optimize interventions and bridge the
gap between clinical trials and community care.
Center for Technology and Behavioral
Health—Workshop
The Center for Technology and Behavioral Health (CTBH; a
P30 Center of Excellence supported by the National Institute
on Drug Abuse [NIDA] at the National Institutes of Health) is
an interdisciplinary research center at Dartmouth College
focused on the goal of harnessing existing and emerging
technologies to effectively develop and deliver evidence-based
interventions for substance use and co-occurring disorders [14].
In total, 3 primary cores, treatment development and evaluation
(TDE), emerging technologies and data analytics, and
dissemination and implementation, bring together a diverse
team with expertise in addiction science, behavioral health
intervention, technology development, computer science and
engineering, digital security, health economics, and
implementation science.
The TDE core of the CTBH organized a workshop,
“Development and Evaluation of Digital Therapeutics for
Behavior Change: Science, Methods, and CTBH Projects,”
which was recently held on the campus of Dartmouth College.
This was one of the series of workshops launched by the CTBH
to encourage and expand collaboration among Dartmouth
scientists and international CTBH affiliates across the diverse
disciplines that engage in research related to digital technology
and behavioral health. The goals of the workshop were to (1)
highlight key conceptual and scientific issues vital to the
proliferation of research on digital therapeutics, (2) stimulate
new collaborations and scientific developments, and (3)
showcase the work of CTBH-TDE core investigators. The
workshop theme was the Science of Behavior Change. More
than 50 faculty, students, trainees, and staff attended this all-day
meeting in person, and collaborative partners from a number of
US institutions and ETH Zürich’s Center for Digital Health
Interventions attended remotely. This paper summarizes the
workshop sessions, which addressed (1) principles of behavior
change; (2) conceptual frameworks for optimizing applications
in mental health, addictive behavior, and health behavior change;
and (3) the diversity of experimental methods and designs that
are essential to the successful development and testing of digital
therapeutics for behavior change. Most sessions also provided
examples of ongoing projects focused on identifying and
improving the measurement of health behavior change
mechanisms and the development and evaluation of digital
therapeutics. Our goal here was to use the knowledge gleaned
during this workshop to provide a broad overview of the
wide-ranging research topics that must be addressed to advance
the field of digital health and its impact on health behavior
problems and to illustrate how our CTBH model can facilitate
progress in meeting the vast health challenges facing behavioral
health research and service delivery models.
Science of Behavior Change
WA, the Director of the NIDA’s Behavioral Therapy
Development Program in the Clinical Research Grants Division,
provided opening comments and highlighted NIDA’s keen
interest in research on behavior change and mechanisms of
change in research on addictions. He emphasized how science
that targets potential change mechanisms, such as
self-regulation, stress, resilience, and intra- and interpersonal
processes, can have a ubiquitous impact on our ability to provide
more focused and parsimonious treatments, that is, personalized
medicine. WA concluded with a discussion of how the
integration of technology-based treatments can uniquely target
and facilitate change in these mechanisms and thereby advance
the development of effective interventions for substance use
and associated psychiatric disorders.
As the workshop audience comprised a diverse group of
multidisciplinary scientists who affiliate themselves with the
CTBH, AB began with an overview of key principles of
behavior change, from basic theories of learning (eg, Skinnerian
principles of reinforcement) to current behavioral economic
concepts that are highly relevant to identifying and targeting
effective behavioral health change mechanisms. This
presentation illustrated how understanding the basic elements
of behavior change principles can be translated into
personalized, effective treatment elements. As examples, AB
described how novel translations of behavior analytic principles
of reinforcement and the construct of temporal discounting have
been applied to inform the development of innovative treatment
strategies that can enhance treatment outcomes for substance
use disorders and other health behavior problems [15-17]. He
also shared other heuristic behavioral economic principles that
are currently being transformed into tools designed to optimize
health behavior change [17] and discussed the many ways that
technology can be leveraged to facilitate and accelerate the
creation and dissemination of effective behavior change
interventions.
JD then initiated a series of presentations that underscored the
importance of using diverse and innovative methodologies and
experimental designs to advance research on digital
technology–based treatments. He introduced and discussed the
key role that single-case experimental designs (SCEDs) can
play in stage 1 testing of technology-based interventions to
promote health behavior [18,19]. He illustrated how SCEDs
can rigorously and efficiently answer questions about the
preliminary efficacy and acceptability of an intervention. He
reviewed the essential methodological elements of SCEDs and
used examples from his published research on technology-based
methods to promote smoking cessation to illustrate these
elements [20]. In addition, he discussed how SCEDs can be
employed to evaluate potential mechanisms underlying
intervention efficacy. Specifically, mechanisms can be assessed
by obtaining a time series of changes in measures of the
mechanism construct and the outcome and by experimentally
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manipulating the mechanism using SCEDs. JD concluded by
noting some of the practical and scientific advantages of SCEDs
and how their use encourages data intimacy, scientific rigor,
and innovation.
CS’s presentation alerted the audience to several emerging
research methods and designs that may be particularly useful
in evaluating and understanding the impact of technology-based
tools on health behavior and that can supplement the findings
from RCTs (eg, the Multiphase Optimization Strategy and
Sequential Multiple Assignment Randomized Trial [SMART])
[21-23]. CS focused on SMART designs, which involve random
assignment of individuals to conditions more than once during
a study, based on their response to conditions experienced earlier
in the study. As SMART designs involve multiple
randomizations over time, they test the impact of applying
different intervention approaches at critical decision points
based on intervention response. CS presented an example of a
recently completed SMART trial for adolescent cannabis use
[24]. Using a SMART design, this study tested the impact of
an initial intervention (adding working memory training to
contingency management [CM] for youth with cannabis use
disorder at treatment onset) and an adaptive intervention
(switching youth who did not show a positive response after
the first month of the intervention to higher magnitude CM
incentives) on clinical outcomes. CS summarized how the
SMART design fits particularly well with digital interventions
because rapid assessment of changing (dynamic) predictors of
intervention response and adaptive changes in intermediate
outcomes in response to interventions are facilitated by the
technology. This effort may lead to technology-based tools that
can be readily tailored to optimally meet the needs of an
individual [25].
Mechanism of Action and Measurement
The workshop shifted focus with LM’s presentation on targeting
mechanisms of action with digital therapeutics, in this case,
self-regulation. She first raised awareness of the ubiquitous
contribution and challenges that health risk behavior and poor
adherence to medical regimens impart on chronic disease
development and its management. Self-regulation, a person’s
ability to manage cognitive, motivational, and emotional
resources to act in accordance with his or her long-term goals,
was introduced as an important causal mechanism of health
behavior, and deficient self-regulation was proposed as a key
target for interventions addressing health risk behavior in
chronic diseases. LM outlined existing but disparate literature
that highlights the clear promise of interventions that target
self-regulation to improve health and the challenges that must
be addressed if we are to most effectively address this
transdisease process of self-regulation [12]. Examples were
provided of how digital technology and data analytics have
created unprecedented opportunities to assess and modify
self-regulation and thus accelerate scientific understanding and
application. Intensive and continuous individual data collection
with mobile devices (or passive sensors and digital footprints
of Web-based social media) can provide rich personal and
environmental data in real time, which sophisticated data
analytics can turn into meaningful insights about individual
health and inform person-centered adaptive interventions.
LM discussed an ongoing National Institutes of Health funded
ontology of self-regulation project that involves the development
of optimal measures of self-regulation using the aforementioned
digital technology and data analytic methods and evaluation of
how the mechanism of self-regulation relates to behavior change
across 2 clinical populations (heavy smokers and persons with
binge eating disorder) [12]. Participants will use a mobile health
self-regulation platform that provides science-based behavior
change tools to promote improved self-regulation and health
behavior and facilitate real-time data collection.
ES provided more detail on the first stage of this project, that
is, the application of data analytics to the development of a
momentary measure of self-regulation that can be used to
effectively evaluate change constructs in naturalistic settings
via mobile devices in trials using digital therapeutics to assess
and treat health behavior problems. She described the iterative
process and innovative data analytics involved in empirically
extracting the most informative items derived from the multitude
of items contained within the many existing self-regulation
assessments to efficiently capture momentary self-regulation
status with a brief measure in longitudinal studies. ES showed
data from an initial piloting of this 20-item measure using
ecological momentary assessment (3 times per day surveys for
2 weeks). Her team used multilevel factor analysis to select 12
items that represented 4 valid self-regulation subscales
(perseverance, self-judgment, sensation seeking, and
mindfulness). CTBH affiliates have included this momentary
measure to assess changes in self-regulation in 4 clinical studies.
The next 2 presentations illustrated the novel advances in
measurement that passive sensing can bring to the study of
behavioral health by providing examples of how mobile sensing
can be used to identify temporal fluctuations in high-risk
emotional states (eg, depression and stress). AC described his
ongoing project focused on the high rates of depression and
anxiety among college students. His study used passive sensing
features of a smartphone and a commodity wrist-worn wearable
(Microsoft Band2; Microsoft, WA) to monitor multiple
behavioral and physiological correlates of depression over time
(eg, activity level, conversation frequency, and sleep duration)
[26]. These devices monitored location, phone usage, light and
sound detection, activity duration (steps), heart rate, skin
temperature, and galvanic skin response over 10 weeks, and
text messages prompted collection of weekly patient health
questionnaire depression scores and other experience sampling
responses. Data analytic models using all these data and pre-post
surveys that assessed stress, anxiety, productivity, and other
relevant behavior or emotions were combined to determine how
the passive sensing measures related to the students’ mental
health functioning across the semester.
In an excellent example of cross-discipline collaboration, SL
presented results from a proof-of-concept pilot study conducted
with members of Dartmouth’s Computer Science and
Engineering Sciences Departments to evaluate the reliability
and acceptability of a wearable sensor system (called the Amulet
Sensor System, a wrist-worn device developed at Dartmouth)
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to passively identify stress in a college student population. The
sensor system included a commodity chest strap heart rate
monitor to collect heart rate variability data, an electrodermal
activity sensor to assess skin conductance data, and the Amulet
that acted as a data hub for data from the heart rate monitor.
The Amulet included an accelerometer and software to conduct
an ecological momentary assessment of stress constructs as well
as an event mark feature to benchmark high-stress periods. SL
discussed results about the feasibility of using commodity
products for passive detection of stress and the potential of
passive sensing techniques as the first line of assessment to
trigger just-in-time interventions [27]. The discussion
highlighted the importance and roles of multidisciplinary team
of scientists from the fields of behavioral health, computer
science, and engineering in the development and evaluation of
digital approaches to behavioral health.
Clinical Application
The workshop then shifted to a more clinical focus as EN
discussed the problem of intervention adherence in clinical trials
using digital health tools, an issue similar to that which occurs
with traditional behavioral and pharmacological interventions.
He provided examples about how some technology-based
interventions can reduce dropout compared with traditional
therapist-delivered interventions for substance use disorders
but noted that both approaches still have high rates of attrition.
EN highlighted that more attention to increased production
value, that is, more consumer-friendly user interface and user
design, or gamification, could help address this vital adherence
issue with behavioral health populations. He provided 2
examples of efforts in this direction, one that included
high-quality video demonstrations to enhance development of
coping skills in the context of treating substance use disorders
[28] and one that is using gamification within a digital
therapeutic for treating opioid use disorder [29], but he stressed
the need to empirically test the assumption that these innovations
positively impact adherence. EN showed data illustrating how
a digital therapeutic tool had improved adherence to a
buprenorphine medication regimen in the treatment of opioid
dependence [30] and concluded with a discussion of other ideas
for how technology could enhance treatment adherence, for
example, remote camera (smartphone) monitoring and
confirmation, facial recognition software combined with pill
ingestion, automated messaging, and motivational prompts.
The following series of presentations described ongoing digital
health projects of the CTBH faculty and affiliates. Each of them
highlighted behavior change methods, experimental design
features, and potential next steps in their development efforts.
First, MB described the development and testing of a mobile
intervention to deliver motivational education for smoking
cessation tailored for young adults with serious mental illness.
She discussed the importance of reducing and quitting smoking
to prevent the disparate chronic diseases in this vulnerable
population and how design features of digital therapeutics need
to be tailored to the special needs of the clinical population to
optimize potential efficacy [31]. Her initial pilot study
demonstrated increased quit attempts and increased biologically
verified smoking abstinence compared with 2 control groups
[32].
Next, WT described an international project called Detection
and Integrated Care for Depression and Alcohol Use in Primary
Care, which is funded by the Research Partnerships for Scaling
Up Mental Health Interventions in Low- and Middle-Income
Countries (Scale-Up Hubs) program of the National Institute
of Mental Health. The project seeks to build sustainable research
capacity and science-based programs in Latin America while
simultaneously creating new knowledge to inform science-based
approaches to scaling up mental health implementation research
[33,34]. In Latin America, the burden of mental health problems
is high, and services for mental health care are low. Expanding
access to mental health care in a way that can be quickly scaled
and have a substantial impact on the population is a significant
global challenge. This project involves training the Latin
American primary care workforce to use digital technology to
enhance screening and diagnosis and to deliver treatment for
depression and substance use via a science-based mobile digital
therapeutic tool.
The next set of presentations illustrated how social media can
be leveraged for conducting digital epidemiological studies,
developing and testing of digital therapeutics, and in-person
recruitment for traditional clinical trials. JB reported on a
particularly cost-effective means of using social media to recruit
adult and adolescent populations with unique characteristics.
He highlighted existing literature demonstrating that such
methods can be used to recruit clinically relevant populations
(eg, persons with depression or HIV, electronic cigarette users,
and those with alcohol use problems). He then described a series
of studies conducted at CTBH using Facebook advertising
mechanisms to recruit large and diverse samples of individuals
who use cannabis and discussed the rich clinical epidemiological
datasets that were obtained [35,36]. Such studies have provided
valuable insights into policy impact, cannabis use
phenomenology, and cannabis use benefits and consequences.
He further highlighted how social media can also be leveraged
to locate individuals interested in receiving treatment and for
developing and delivering interventions remotely. AK described
her innovative project that used social media, that is, private
Facebook groups, to recruit adolescents at risk for anxiety and
to remotely elicit their feedback on the design of a digital anxiety
intervention [37]. She discussed how the observed active
engagement and participation of teens in the Web-based focus
group suggest that social media platforms may be an effective
tool to engage and elicit feedback from youth in the early stages
of the intervention design process.
CS concluded the series of demonstration project presentations
by describing her Web-delivered intervention (WebRx) for teens
with type 1 diabetes (T1D) and their parents. Across several
small iterative pilot studies, she developed a novel
multicomponent intervention that targeted adherence to
self-management behaviors necessary to manage T1D [38].
Adherence-focused strategies include incentives for youth for
objectively defined and tracked adherence behaviors, incentives
for parents for daily monitoring of youth adherence, and
Web-based health coaching to promote effective use of diabetes
device data, and digitally delivered working memory training
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for the teens. CS described results from an RCT that
demonstrated the superiority of WebRx, which engendered
higher self-monitoring of blood glucose, better visual-spatial
working memory and inhibition, lower hemoglobin A1c levels
than those receiving usual care, more frequent parent review of
the adolescent’s glucometer, and reduced family conflict [38].
The presentation concluded by focusing on how this highly
disseminable intervention focused on promoting the effective
use of technology and software to monitor and improve medical
outcomes.
Conclusions and Future Directions
This workshop brought together a collaborative group of junior
and senior scientists from a diverse array of disciplines,
including clinical and experimental psychology, data science
and analytics, psychiatry, computer science, and population
health, all interested in the same goal, that is, advancing digital
therapeutics to improve health behavior. The presentations and
discussions illustrated how scientists across these disciplines
can learn from each other and jointly expedite the potential of
technological innovation for improving public health and health
care and how the science of behavior change is essential for
maximizing the impact of this endeavor. Workshop participants
endorsed finding additional meaningful ways to bring these
seemingly disparate groups of scientists together more
frequently. Many acknowledged that this was necessary to
accelerate this area of science because of the multitude of
phenomena involved in optimizing health and health research,
for example, complexity of behavior, behavior change,
assessment, measurement, big data analytics, intervention
design, experimental design, technology capabilities and
limitations, motivation for change, adherence to treatment
regimens, and for optimal communication, dissemination,
implementation, and sustainability of effective discoveries.
Attendees expressed an eagerness to participate in future
workshops or alternative interdisciplinary activities that would
better connect them to their colleagues and promote more
collaborative project proposals. This workshop, the second of
a planned series of 3 CTBH workshops corresponding to the
Center’s 3 scientific cores [39], confirmed and clearly illustrated
the value of these types of structured activities for fostering
greater collaboration among our interdisciplinary faculty and
scientists. Complimentary ideas for the future included more
in-depth workshops focused on deep dives into specific topics,
organization of cross-disciplinary student and trainee journal
clubs, use of alternative formats for workshops with built in
time for small interdisciplinary group discussion, and the
continued development of CTBH pilot funding opportunities
that require specified cross-discipline collaborations.
In summary, our workshop on the development and evaluation
of digital therapeutics for health behavior change showcased
the myriad research targets that will be instrumental in
promoting and accelerating progress in the field of digital health
and health behavior change. The CTBH at the Geisel School of
Medicine at Dartmouth College provides a model of
multidisciplinary leadership and collaboration that can facilitate
innovative, science-based efforts to address the health behavior
challenges afflicting our communities by engaging and guiding
teams of scientists to conduct research that will provide the
knowledge and tools to inform more effective public health
programming.
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